JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walter, B. N.
Right arrow Articles by Traugh, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walter, B. N.
Right arrow Articles by Traugh, J. A.

J Biol Chem, Vol. 273, Issue 44, 28733-28739, October 30, 1998


Cleavage and Activation of p21-activated Protein Kinase gamma -PAK by CPP32 (Caspase 3)
EFFECTS OF AUTOPHOSPHORYLATION ON ACTIVITY*

Barbara N. WalterDagger , Zhongdong HuangDagger , Rolf JakobiDagger §, Polygena T. TuazonDagger , Emad S. Alnemri, Gerald Litwackparallel , and Jolinda A. TraughDagger **

From the Dagger  Department of Biochemistry, University of California, Riverside, Riverside, California 92521, and the  Department of Microbiology and Immunology and the parallel  Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

p21-activated protein kinase gamma -PAK (Pak2, PAK I) is cleaved by CPP32 (caspase 3) during apoptosis and plays a key role in regulation of cell death. In vitro, CPP32 cleaves recombinant gamma -PAK into two peptides; 1-212 contains the majority of the regulatory domain whereas 213-524 contains 34 amino acids of the regulatory domain plus the entire catalytic domain. Following cleavage, both peptides become autophosphorylated with [gamma -32P]ATP. Peptide 1-212 migrates at 27,000 daltons (p27) upon SDS-polyacrylamide gel electrophoresis and at 32,000 daltons following autophosphorylation on serine (p27P); the catalytic subunit migrates at 34,000 daltons (p34) before and after autophosphorylation on threonine. Following caspase cleavage, a significant lag (~5 min) is observed before autophosphorylation and activity are detected. When gamma -PAK is autophosphorylated with ATP(Mg) alone and then cleaved, only p27 contains phosphate, and the enzyme is inactive with exogenous substrate. After autophosphorylation of gamma -PAK in the presence of Cdc42(GTPgamma S) or histone 4, both cleavage products contain phosphate and gamma -PAK is catalytically active. Mutation of the conserved Thr-402 to alanine greatly reduces autophosphorylation and protein kinase activity following cleavage. Thus activation of gamma -PAK via cleavage by CPP32 is a two-step mechanism wherein autophosphorylation of the regulatory domain is a priming step, and activation coincides with autophosphorylation of the catalytic domain.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In response to a variety of death stimuli, the caspase family of cysteinyl aspartate-directed proteases becomes activated. The caspases play integral roles in apoptosis or programmed cell death, which include a number of morphological changes such as nuclear condensation, membrane and cytoskeletal rearrangement, and formation of apoptotic bodies (for review, see Ref. 1). CPP32 (caspase 3) is cleaved to p20 and p10 (2) and has been shown to participate in apoptosis through cleavage of a number of proteins including DNA-activated protein kinase (3) and protein kinase C-related kinase (4), among others (5). Recently, Rudel and Bokoch (6) and Lee et al. (7) have shown that the p21-activated protein kinase gamma -PAK1 (Pak2, PAK I) is constitutively activated via cleavage by CPP32 following induction of apoptosis in Jurkat cells.

gamma -PAK is the ubiquitous isoform of a family of protein kinases activated by the small G proteins Cdc42 and Rac. The G protein binding site is in the amino-terminal regulatory domain, whereas the carboxyl terminus consists of a highly conserved catalytic domain (see Refs. 8 and 9 for review). gamma -PAK was initially purified as an inactive holoenzyme from rabbit reticulocytes that could be activated by limited digestion with trypsin (10). It has a calculated molecular weight of 58,015 and migrates at 58-60 kDa on SDS-PAGE (11). gamma -PAK has been shown to phosphorylate multiple substrates including histones H2B and H4 (10), myosin light chain (12, 13), and Rous sarcoma virus protein NC (14, 15).

gamma -PAK has also been implicated in cytostasis, as shown by injection of subfemtomole amounts of gamma -PAK into 1 blastomere of 2-cell frog embryos, whereupon cleavage of the injected blastomere is inhibited while the noninjected blastomere continues through mid-cleavage (16). A protein of 58,000 Da that reacts with antibody to gamma -PAK from rabbit is present in high amounts in frog oocytes and is greatly diminished following fertilization, suggesting gamma -PAK is involved in maintaining oocytes in a nondividing state (16). In dividing 3T3-L1 cells, gamma -PAK is primarily in an inactive form. Active gamma -PAK becomes the predominant form in the cytoplasm when 3T3-L1 cells are serum-starved or enter the quiescent state.2

Inactive gamma -PAK and two endogenously active forms have been purified from rabbit reticulocytes,3 whereas wild type and mutant forms of recombinant gamma -PAK from rabbit have been expressed in insect cells (17). In the studies described herein, the requirements for activation of recombinant gamma -PAK via cleavage with recombinant CPP32 have been analyzed. Cleavage produces 2 peptides, p27 containing the majority of the regulatory domain and p34 containing part of the regulatory domain and the entire catalytic domain, both of which become autophosphorylated. A comparison of autophosphorylation and activity of wild type and mutant gamma -PAK shows autophosphorylation is a bipartate mechanism, with the regulatory domain (p27) autophosphorylated at multiple residues, while activation coincides with autophosphorylation of the catalytic domain (p34) at Thr-402.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- TALON-NX metal resin was from CLONTECH; Immobilon PSQ was from Millipore. Histone 4 and GTPgamma S were from Boehringer Mannheim. [gamma -32P]ATP was from NEN Life Science Products; human thrombin and other chemicals were from Sigma. Antibody prepared to a highly conserved sequence in the catalytic region of STE20 from Saccharomyces cerevisiae was purchased from Upstate Biotechnology. pAcG2T was from PharMingen. Antibody prepared in rat to gamma -PAK purified from rabbit reticulocytes (16) was provided by Dr. Regina Rooney. The clone for GST-Cdc42 was generously provided by Dr. Channing Der, University of North Carolina, Chapel Hill, NC. Peptide S3 (AKRESAA) was synthesized as described previously (18).

Expression and Purification of CPP32 from BL21(DE3) Cells-- A construct containing an open reading frame for the CPP32 gene attached to a His6 tag in the pET21(b) vector was used to transform BL21(DE3) cells. Recombinant CPP32 was obtained from 500 ml of culture induced with isopropyl-1-thio-beta -D-galactopyranoside for 3-4 h at 37 °C. The supernatant was chromatographed on 0.3 ml of TALON-NX resin and washed, and His-tagged CPP32 was eluted with 50 mM imidazole. CPP32 activity in the eluate was monitored by cleavage of gamma -PAK. A unit of CPP32 is identified as the amount of enzyme that cleaves 1 µg of gamma -PAK in 20 min at 37 °C.

Expression of Recombinant gamma -PAK in Insect Cell Cultures-- The cDNA for gamma -PAK and the mutants K278R, S401A, T402A, S490A, and S490D was cloned into the pAcG2T vector and used to transfect TN5B-4 cells (17). The cells were lysed on day 2, and the recombinant protein was purified by affinity chromatography on glutathione-Sepharose. GST-gamma -PAK (p90) was released from the beads with 5 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0, or was cleaved with 1 unit/ml of thrombin in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 2.5 mM CaCl2 to produce gamma -PAK (p58).

Activation of gamma -PAK and Assays for Activity-- Cleavage of gamma -PAK by CPP32 was carried out in a volume of 60 µl containing 25 mM Hepes, pH 7.5, 5 mM EDTA, 2 mM dithiothreitol, 0.1% CHAPS, 1 µg of phosphorylated or nonphosphorylated PAK, and 1 unit of CPP32. Incubation was at 37 °C for 30 min and was terminated by the addition of SDS sample buffer. Activation of gamma -PAK (0.10 µg) was carried out in the presence and absence of GST-Cdc42(GTPgamma S) or histone 4 (2.0 µg) as described (11). Autophosphorylation was carried out in 70 µl of reaction mixtures containing 20 mM Tris-HCl (pH 7.4), 10 mM MgCl2, 15 mM 2-mercaptoethanol, 0.2 mM [gamma -32P]ATP (500-2000 dpm/pmol). Incubation was for 15 min at 30 °C. Autophosphorylation and cleavage were analyzed by SDS-PAGE on 12% polyacrylamide gels followed by staining with Coomassie Blue.

Activity assays were carried out under kinetically valid conditions with the synthetic peptide S3 (AKRESAA; 1.0 mM), as described previously, with 0.1 µg of gamma -PAK (18). The reactions were terminated by addition of 7 µl of 100 mM nonradioactive ATP, and phosphorylated S3 was analyzed on P81 phosphocellulose paper. Under these conditions, less than 10% of the substrate was phosphorylated and phosphate incorporation was linear with time.

Microsequencing of gamma -PAK-- GST-gamma -PAK (10 µg) was cleaved with 10 units of CPP32 for 30 min at 37 °C in a final volume of 100 µl, and the products were separated by SDS-PAGE. The peptides were transferred to Immobilon PSQ in 10 mM CAPS (pH 11) and 10% methanol by semi-dry blotting. The proteins were stained with Coomassie Blue for 20 s, destained with 50% methanol, and washed with water. The p34 peptide was excised and sequenced using an Applied Biosystems Procise Sequencer.

Identification of the Cleavage Products of gamma -PAK by Western Blotting-- gamma -PAK, GST-gamma -PAK, and the CPP32-generated peptides were subjected to SDS-PAGE and transferred by electroblotting to nitrocellulose membranes. The samples were probed with anti-STE20 antibody or anti-gamma -PAK antibody diluted 1/1000. These antibodies reacted specifically with the catalytic and regulatory domains, respectively, and were detected with peroxidase-conjugated secondary antibody and by chemiluminescence with the Amersham Pharmacia Biotech ECL detection kit.

Tryptic Phosphopeptide Mapping and Phosphoamino Acid Analysis-- gamma -PAK was cleaved with CPP32 and autophosphorylated with [gamma -32P]ATP, and the phosphorylated cleavage products were analyzed by SDS-PAGE. The 32P-labeled products were extensively digested with trypsin. Following phosphopeptide mapping, individual peptides were excised and sequentially eluted with 0.5 ml each of 0.5 M acetic acid, water, and 0.5 M pyridine. The eluates were pooled, dried by Speed-vac, and hydrolyzed with 6 N HCl. Phosphoamino acid analyses were carried out as described previously (19, 20). 32P-labeled peptides were detected by phosphor screen autoradiography.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cleavage of Purified gamma -PAK by CPP32-- gamma -PAK (p58) and GST-gamma -PAK (p90) cloned from rabbit, and expressed in insect cells, were subjected to cleavage by the caspase CPP32. As shown by Coomassie Blue stain, p58 was cleaved into two peptides, p27 and p34, whereas cleavage of p90 resulted in peptides migrating at p53 and p34 on SDS-PAGE (Fig. 1, lanes 1 and 3). To identify the cleavage products, antibodies prepared to amino acids in the catalytic region of STE20, or to purified gamma -PAK from rabbit, which reacted specifically with the regulatory region, were used. The STE-20 antibody reacted with p58 and GST-gamma -PAK p90; following cleavage with CPP32, an additional band was detected that migrated with a molecular weight of 34,000 (p34), indicating p34 contained the catalytic domain. Antibody prepared to rabbit gamma -PAK reacted with p58 and p90. Upon cleavage of p58, a single peptide migrating with a molecular weight of 27,000 (p27) was detected; a peptide of 53,000 daltons (p53) was detected with GST-gamma -PAK, which contained GST-p27.


View larger version (87K):
[in this window]
[in a new window]
 
Fig. 1.   Identification of the cleavage products of gamma -PAK by CPP32. gamma -PAK p58 (top panels) and GST-gamma -PAK (p90) (bottom panels) were incubated in the absence and presence of CPP32 as described under "Experimental Procedures" and then incubated in the absence and the presence of nonradioactive ATP for 15 min. The proteins and their cleavage products were identified by Coomassie stain and by Western blotting with anti-gamma -PAK, which reacted specifically with the regulatory domain, and with anti-STE20 antibody, which reacted with the catalytic domain. gamma -PAK (p58), GST-gamma -PAK (p90), and the cleavage products are indicated by molecular mass. Lane 1, CPP32 and ATP omitted; lane 2, CPP32 omitted, ATP added; lane 3, CPP32 added, ATP omitted; and lane 4, CPP32 and ATP added.

The p34 peptide was subjected to microsequence analysis, and the sequence obtained was identical to the sequence calculated from the rabbit cDNA for gamma -PAK beginning with amino acid 213 (Fig. 2, top panel). Thus, p34 contained the entire catalytic domain of gamma -PAK, which began at amino acid 247, as well as 34 amino acids of the regulatory domain (Fig. 2, bottom panel). The cleavage site was consistent with the sites identified previously for caspase 3 and coincided with that identified for gamma -PAK during apoptosis using peptide inhibitors and the mutant D212N (6). The CPP32 cleavage site was 16 amino acids from the major site of trypsin cleavage at arginine 195 which produced the active peptide p37 (11).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Identification of cleavage sites and diagram of gamma -PAK. Microsequence analysis of p34 was carried out as described under "Experimental Procedures." The identified sequence is compared with the sequence calculated from the cDNA (11). The diagram of gamma -PAK shows the cleavage site for CPP32 (p34) and the major trypsin cleavage site (p37). The positions of mutations used herein are identified.

Autophosphorylation of gamma -PAK following Cleavage by CPP32-- gamma -PAK and GST-gamma -PAK p90 were cleaved by CPP32, then autophosphorylated, and then compared with the noncleaved PAK. Western blotting was carried out with antibody to the regulatory and catalytic domains as shown in Fig. 1, lanes 2 and 4. No Coomassie Blue-stained peptides were observed in the absence of protease. Antibody to the catalytic domain detected a single peptide of 34,000 Da. With antibody to the regulatory domain, a single peptide of 32,000 Da was detected (p27P) when gamma -PAK was autophosphorylated following caspase cleavage. This indicated that all of the p27 peptide had become autophosphorylated which resulted in retarded migration on SDS-PAGE. A slightly retarded migration was also detected with autophosphorylated p53 (p53P) cleaved from GST gamma -PAK p90.

To examine the effects of autophosphorylation on protein kinase activity, gamma -PAK was cleaved with CPP32 and then incubated with radiolabeled ATP for up to 15 min, and analyzed by autoradiography following SDS-PAGE. As shown in Fig. 3, top panel, some autophosphorylation of both p27 and p34 was observed at 5 min, after which autophosphorylation of both peptides increased with time. The increased level of autophosphorylation was concomitant with an increased retardation of the migration of p27 in SDS-PAGE gels.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 3.   Analysis of autophosphorylation and activity of gamma -PAK following cleavage by CPP32. gamma -PAK (p58) was cleaved with CPP32 and autophosphorylated with [gamma -32P]ATP for up to 30 min (top panel; the autoradiogram is shown). The peptide substrate was added either at 0 time or added after prephosphorylation for 15 min and then phosphorylated for the times indicated (bottom panels).

To measure gamma -PAK activity, the heptapeptide S3, which was shown previously to be a specific substrate for PAK (18), was added to the reaction mixture at 0 time or after 15 min of autophosphorylation. The rate of phosphorylation of S3 correlated with the extent of autophosphorylation of gamma -PAK. As shown in Fig. 3, bottom panel, no significant phosphorylation of S3 was observed until a sufficient level of autophosphorylation had been reached at 5 min. After that time, the rate of phosphorylation was linear with time. In contrast, the rate of phosphorylation of S3 with gamma -PAK prephosphorylated for 15 min was essentially linear for the entire 15 min incubation period.

Autophosphorylation of gamma -PAK Prior to Cleavage by CPP32-- As shown previously, gamma -PAK can be activated by binding of Cdc42(GTPgamma S) or by the substrate histone 4 (17, 21). To examine the effects of autophosphorylation of gamma -PAK on cleavage by CPP32, the protein kinase was preincubated with ATP(Mg) alone, with histone 4, with Cdc42, or with Cdc42(GTPgamma S). When gamma -PAK p58 was autophosphorylated with ATP(Mg) alone and then subjected to cleavage, only the p27 peptide contained phosphate and migrated with a molecular mass of p32 (p27P) (Fig. 4, left panel). The identity of this peptide was confirmed by Western blotting and phosphopeptide mapping (see below). In the presence of histone 4, autophosphorylation of p58 was increased 14-fold over that obtained with ATP(Mg) alone, and caspase cleavage showed both the catalytic and regulatory domains contained phosphate. In the presence of Cdc42 alone, the results were identical to those obtained with ATP(Mg). With Cdc42(GTPgamma S), autophosphorylation of gamma -PAK p58 was highly stimulated. Following cleavage, both p27 and p34 were phosphorylated, along with a slightly smaller fragment. In contrast, with GST-gamma -PAK, only a small amount of autophosphorylation was observed with ATP(Mg) alone or with Cdc42 (Fig. 4, right panel). Cleavage with CPP32 showed this phosphate was in p53P. In the presence of histone 4 or Cdc42(GTPgamma S), p90 was highly autophosphorylated; upon cleavage, both p53 and p34 contained phosphate.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 4.   Analysis of autophosphorylation prior to cleavage of gamma -PAK by CPP32. gamma -PAK (left panel) and GST-gamma -PAK (right panel) were autophosphorylated alone, in the presence of histone 4, in the presence of Cdc42, and in the presence of Cdc42(GTPgamma S) for 15 min, and then cleaved with CPP32. The autoradiograms are shown. The proteins and peptides are indicated by molecular mass.

To analyze the effects of autophosphorylation of gamma -PAK on activity following caspase cleavage, gamma -PAK was prephosphorylated in the presence or absence of Cdc42(GTPgamma S) and then incubated in the presence and absence of CPP32. Activity assays with peptide S3 were carried out for up to 10 min. As shown in Fig. 5, top panel, prephosphorylation in the presence of Cdc42(GTPgamma S) prior to substrate addition at 15 min resulted in a high level of phosphate in p58 or in p27 and p34. In contrast, upon prephosphorylation in the absence of Cdc42, the amount of phosphate present in p58 or p27P at 0 time was significantly less, and little or no phosphate was present in p34. Incubation of the cleaved products with ATP(Mg) resulted in both p27 and p34 becoming highly autophosphorylated within 1 min (data not shown). Thus, autophosphorylation of the regulatory domain in the absence of Cdc42(GTPgamma S) primed the protein kinase for rapid autophosphorylation of the catalytic domain following cleavage.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 5.   Correlation of autophosphorylation of gamma -PAK prior to cleavage with protein kinase activity. gamma -PAK (p58) was autophosphorylated in the presence and absence of Cdc42(GTPgamma S) for 15 min and then incubated in the presence or absence of CPP32. Top panel, samples (30 µl) were analyzed by SDS-PAGE; the autoradiogram is shown. Middle panel, the same samples (30 µl) were assayed for protein kinase activity with peptide S3 for 10 min. Bottom panel, a time course of protein kinase activity was carried out with gamma -PAK prephosphorylated prior to cleavage and compared with gamma -PAK autophosphorylated after cleavage (taken from Fig. 3).

When protein kinase activity was measured at the 10 min time point, little phosphorylation of peptide S3 was observed with p58 prephosphorylated with ATP(Mg) alone (Fig. 5, middle panel). A significant stimulation of activity (3-fold) was observed with p58 prephosphorylated in the presence of Cdc42(GTPgamma S). Upon cleavage of gamma -PAK prephosphorylated in the presence and absence of Cdc42(GTPgamma S), the activity was significantly higher, a 10-fold stimulation over the noncleaved enzyme. A time course showed that at 2.5 min, the activity of cleaved gamma -PAK prephosphorylated in the presence and absence of Cdc42(GTPgamma S) was identical. No lag phase was observed with any of the prephosphorylated samples (Fig. 5, bottom panel). This coincided with the rapid autophosphorylation observed following cleavage. Similar results were obtained within 1 min of cleavage (data not shown). Thus autophosphorylation of the regulatory domain was the priming step in activation, but phosphorylation of Thr-402 on the regulatory domain was required for activity with exogenous peptide substrates.

Autophosphorylation Sites Required for Activity-- Multiple sites of autophosphorylation have been observed with gamma -PAK (17, 21). When the CPP32 cleavage products of gamma -PAK were autophosphorylated, six phosphopeptides were observed with p27P and two phosphopeptides with p34 (Fig. 6). The additive data were similar to the phosphopeptide maps obtained with native and recombinant gamma -PAK p58 activated by Cdc42(GTPgamma S) (17, 21), except that the migration of phosphopeptide 9 in p27 was altered after CPP32 cleavage. This suggested that cleavage altered the migration of one of the tryptic phosphopeptides. Phosphoamino acid analysis of p27 showed autophosphorylation was only on serine. When the two phosphopeptides obtained with p34 were analyzed individually, only phosphothreonine was observed (Fig. 7).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 6.   Phosphopeptide maps of the cleavage products of autophosphorylated gamma -PAK. gamma -PAK was cleaved with CPP32, autophosphorylated with [gamma -32P]ATP, and the peptides were separated by SDS-PAGE. Following extensive digestion with trypsin, the phosphopeptides were mapped as described under "Experimental Procedures." Left panel, phosphorylated p27; middle panel, phosphorylated p34; right panel, schematic of gamma -PAK autophosphorylated in the presence of Cdc42(GTPgamma S). The gray spots indicate phosphopeptides in the regulatory domain; the black spots indicate phosphopeptides in the catalytic domain; the dashed outline indicates phosphopeptide 9 from autophosphorylated p58.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 7.   Phosphoamino acid analysis of the cleavage products of gamma -PAK by CPP32. p27 and tryptic peptides 7 and 8 from p34 were subjected to acid hydrolysis, and the phosphoamino acids were identified as indicated under "Experimental Procedures."

To examine the effects of autophosphorylation further, mutants of gamma -PAK prepared by site-directed mutagenesis were incubated in the presence and absence of CPP32 and then autophosphorylated. As shown in Fig. 8, left panel, no autophosphorylation was observed with the knock-out mutation K278R replacing a conserved lysine in the active site. With T402A, autophosphorylation of p27 and p34 was greatly inhibited, indicating that autophosphorylation of Thr-402 was required for autophosphorylation of the cleaved regulatory domain. With the mutants S401A, S490A, and S490D, both p27 and p34 were autophosphorylated to a similar extent as the recombinant wild type gamma -PAK.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 8.   Autophosphorylation and activity of the cleavage products of wild type and mutant forms of gamma -PAK. Left panel, wild type and mutant forms of gamma -PAK were incubated in the absence and presence of CPP32 and then autophosphorylated with [gamma -32P]ATP for 15 min. The autoradiogram is shown. gamma -PAK and the cleavage products are identified by molecular mass. Right panel, protein kinase activity assayed with peptide S3.

Assays of the protein kinase activity of the gamma -PAK mutants with peptide S3 showed no substrate phosphorylation with K278R (Fig. 8, right panel). With T402A, only 2% of the activity of recombinant wild type gamma -PAK was observed, whereas significant activity was obtained with S401A, S490A, and S490D. Taken together, the data indicated that Thr-402 was the only detectable site of autophosphorylation in p34 and that autophosphorylation of Thr-402 was critical for autophosphorylation of p27 and for phosphorylation of the peptide substrate.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Activation of gamma -PAK can be initiated under different conditions, by binding of small G proteins, in particular Cdc42(GTPgamma S) (11), by association with histone 4 (17, 21), by cleavage with trypsin to form p37 (11), and by cleavage with the caspase CPP32. Cleavage by CPP32 produces two peptides, one containing the majority of the regulatory domain (p27) and the other containing the entire catalytic domain and 34 amino acids of the regulatory domain (p34). Following cleavage, both peptides become highly autophosphorylated, which results in a shift of migration of p27 from 27 to 32 kDa upon SDS-PAGE, as shown by Coomassie Blue staining, Western blotting, and radiolabeling. Autophosphorylation of p34 does not alter the migration pattern on SDS-PAGE but is required for activity, as shown with the peptide S3 (AKRESAA).

Prior to cleavage, autophosphorylation of gamma -PAK with ATP(Mg) alone or with Cdc42 in the absence of GTPgamma S results in a similar shift in p27 during SDS-PAGE; however, no autophosphorylation of p34 is observed. Under these conditions, there is little protein kinase activity. Incubation in the presence of Cdc42(GTPgamma S) stimulates autophosphorylation of gamma -PAKp58 by 2.5-fold, and the phosphate is found in both p27 and p34 following cleavage. With Cdc42(GTPgamma S), protein kinase activity as determined with peptide S3 is observed both before and after cleavage. There is a 3-fold stimulation of p58 activity and a 10-fold stimulation following caspase cleavage. Similar results are obtained following autophosphorylation of p58 and the two cleavage products in the presence of histone 4. These data indicate that the cleaved enzyme has a higher level of activity than the Cdc42-activated enzyme.

Autophosphorylation of the regulatory domain is the priming step in activation, and autophosphorylation of p34 on Thr-402 is critical for phosphorylation of peptide substrates. Autophosphorylation is a bipartate mechanism; autophosphorylation of multiple sites in the regulatory domain is a priming step and can occur in the absence of any effectors. Upon caspase cleavage or addition of Cdc42(GTPgamma S) or histone 4, Thr-402 in the catalytic domain is autophosphorylated, resulting in stimulation of protein kinase activity with exogenous substrates. Based on a comparison of sequences of gamma -PAK with the highly studied cAMP-dependent protein kinase (PKA) and cell division kinase 2 (Cdk2), Thr-402 corresponds to the highly conserved threonine, which is located in the p + 1 loop adjacent to the activation loop, as determined by x-ray crystallography (22-25). In PKA and Cdk2, phosphorylation of this threonine is required for activation, as is shown herein for gamma -PAK.

Autophosphorylation of the regulatory domain of the holoenzyme p58 can occur independently of phosphorylation of Thr-402, but autophosphorylation of Thr-402 is required for phosphorylation of exogenous substrates. Following caspase cleavage, autophosphorylation of p27 becomes dependent on a phosphothreonine at position 402, because p27 is now an exogenous substrate.

Previously Rudel and Bokoch (6) showed that gamma -PAK cleavage was correlated with the onset of apoptosis and that the inhibitor of CPP32 cleavage (DEVD-ald) inhibited cleavage of gamma -PAK in Jurkat T cells undergoing apoptosis. The site of cleavage, aspartate 212, was identified using recombinant CPP32 or apoptotic cell lysates which cleaved gamma -PAK into two fragments, but did not cleave the mutant D212N. That data was confirmed herein by direct sequencing of the CPP32 cleavage site generated in vitro.

In other studies, gamma -PAK activity was shown to be high in the cytosol of quiescent and serum-starved cells and to be diminished in dividing cells.2 Thus regulation of gamma -PAK under conditions of growth and quiescence is different from regulation of gamma -PAK during apoptosis. Cleavage by CPP32 allows gamma -PAK to be constitutively active leading to cell death, whereas regulation by Cdc42(GTP) produces gamma -PAK cycling between active and inactive forms.

    ACKNOWLEDGEMENTS

We thank Dr. Regina Rooney for the antibody to gamma -PAK, Dr. Channing Der for GST-Cdc42, and John Ebner for expression and purification of GST-CPP32.

    FOOTNOTES

* This research was supported by National Institutes of Health Grants GM26738 (to J. A. T.), AI/HL 40976 LBPA (to G. L.), and AG 13487 (to E. S. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: Dept. of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226.

** To whom correspondence should be addressed. Tel.: 909-787-4239; Fax: 909-787-3590; E-mail: jolinda.traugh{at}ucr.edu.

The abbreviations used are: PAK, p21-activated protein kinase; PAGE, polyacrylamide gel electrophoresis; GTPgamma S, guanosine 5'-3-O-(thio)triphosphate; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; p53P, autophosphorylated p53; PKA, cAMP-dependent protein kinase; Cdk2, cell division kinase 2.

2 R. D. Rooney, and J. A. Traugh, manuscript in preparation.

3 W. E. Meek, N. Grankowski, P. T. Tuazon, R. D. Rooney, B. Walter and J. A. Traugh, manuscript in preparation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Nagata, S. (1997) Cell 88, 355-365[CrossRef][Medline] [Order article via Infotrieve]
  2. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1994) J. Biol. Chem. 269, 30761-30764[Abstract/Free Full Text]
  3. Han, Z., Malik, N., Carter, T., Reeves, W. H., Wyche, J. H., and Hendrickson, E. A. (1996) J. Biol. Chem. 271, 25035-25040[Abstract/Free Full Text]
  4. Cryns, V. L., Byun, Y., Rana, A., Mellor, H., Lustig, K. D., Ghanem, L., Parker, P. J., Kirschner, M. W., and Yuan, J. (1997) J. Biol. Chem. 272, 29449-29453[Abstract/Free Full Text]
  5. Porter, A. G., Ng, P., and Jänicke, R. U. (1997) Bioessays 19, 501-507[CrossRef][Medline] [Order article via Infotrieve]
  6. Rudel, T., and Bokoch, G. M. (1997) Science 276, 1571-1574[Abstract/Free Full Text]
  7. Lee, N., MacDonald, H., Reinhard, C., Halenbeck, R., Roulston, A., Shi, T., and Williams, L. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13642-13647[Abstract/Free Full Text]
  8. Lim, L., Manser, E., Leung, T., and Hall, C. (1996) Eur. J. Biochem. 242, 171-185[Medline] [Order article via Infotrieve]
  9. Sells, M. A., and Chernoff, J. (1997) Trends Cell Biol. 7, 162-167
  10. Tahara, S. M., and Traugh, J. A. (1981) J. Biol. Chem. 256, 11558-11564[Free Full Text]
  11. Jakobi, R., Chen, C-J., Tuazon, P. T., and Traugh, J. A. (1996) J. Biol. Chem. 271, 6206-6211[Abstract/Free Full Text]
  12. Tuazon, P. T., and Traugh, J. A. (1984) J. Biol. Chem. 259, 541-546[Abstract/Free Full Text]
  13. Ramos, E., Wysolmerski, R. B., and Masaracchia, R. A. (1997) Recept. Signal Transduct. 7, 99-110[Medline] [Order article via Infotrieve]
  14. Leis, J., Johnson, S., Collins, L. S., and Traugh, J. A. (1984) J. Biol. Chem. 259, 7726-7732[Abstract/Free Full Text]
  15. Fu, X., Phillips, N., Jentoft, J., Tuazon, P. T., Traugh, J. A., and Leis, J. (1985) J. Biol. Chem. 260, 9941-9947[Abstract/Free Full Text]
  16. Rooney, R. D., Tuazon, P. T., Meek, W. E., Carroll, E. J., Jr., Hagen, J. J., Gump, E. L., Monnig, C. A., Lugo, T., and Traugh, J. A. (1996) J. Biol. Chem. 271, 21498-21504[Abstract/Free Full Text]
  17. Jakobi, R., Huang, Z., Walter, B. N., Tuazon, P. T., and Traugh, J. A. (1998) FASEB J. 12, A1369
  18. Tuazon, P. T., Spanos, W. C., Gump, E. L., Monnig, C. A., and Traugh, J. A. (1997) Biochemistry 38, 16059-16064
  19. Tuazon, P. T., Merrick, W. C., and Traugh, J. A. (1989) J. Biol. Chem. 264, 2773-2777[Abstract/Free Full Text]
  20. Pendergast, A. M., and Traugh, J. A. (1985) J. Biol. Chem. 260, 11769-11774[Abstract/Free Full Text]
  21. Tuazon, P. T., Chinwah, M., and Traugh, J. A. (1998) FASEB J. 12, A1408
  22. Hanks, S. H., and Quinn, A. M. (1991) Methods Enzymol. 200, 38-62[Medline] [Order article via Infotrieve]
  23. Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N. H., Taylor, S. S., and Sowadski, J. M. (1991) Science 253, 407-414[Abstract/Free Full Text]
  24. Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J., and Pavletich, N. P. (1995) Nature 376, 313-320[CrossRef][Medline] [Order article via Infotrieve]
  25. Johnson, L. N., Noble, M. E. M., and Owen, D. J. (1996) Cell 85, 149-158[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Cathelin, C. Rebe, L. Haddaoui, N. Simioni, F. Verdier, M. Fontenay, S. Launay, P. Mayeux, and E. Solary
Identification of Proteins Cleaved Downstream of Caspase Activation in Monocytes Undergoing Macrophage Differentiation
J. Biol. Chem., June 30, 2006; 281(26): 17779 - 17788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Bhanumathy, S. K. Nakao, and S. K. Joseph
Mechanism of Proteasomal Degradation of Inositol Trisphosphate Receptors in CHO-K1 Cells
J. Biol. Chem., February 10, 2006; 281(6): 3722 - 3730.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Jung and J. A. Traugh
Regulation of the Interaction of Pak2 with Cdc42 via Autophosphorylation of Serine 141
J. Biol. Chem., December 2, 2005; 280(48): 40025 - 40031.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Raney, L. S. Kuo, L. L. Baugh, J. L. Foster, and J. V. Garcia
Reconstitution and Molecular Analysis of an Active Human Immunodeficiency Virus Type 1 Nef/p21-Activated Kinase 2 Complex
J. Virol., October 15, 2005; 79(20): 12732 - 12741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. K. Misra, T. Sharma, and S. V. Pizzo
Ligation of Cell Surface-Associated Glucose-Regulated Protein 78 by Receptor-Recognized Forms of {alpha}2-Macroglobulin: Activation of p21-Activated Protein Kinase-2-Dependent Signaling in Murine Peritoneal Macrophages
J. Immunol., August 15, 2005; 175(4): 2525 - 2533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. K. Misra, R. Deedwania, and S. V. Pizzo
Binding of Activated {alpha}2-Macroglobulin to Its Cell Surface Receptor GRP78 in 1-LN Prostate Cancer Cells Regulates PAK-2-dependent Activation of LIMK
J. Biol. Chem., July 15, 2005; 280(28): 26278 - 26286.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Koeppel, C. C. McCarthy, E. Moertl, and R. Jakobi
Identification and Characterization of PS-GAP as a Novel Regulator of Caspase-activated PAK-2
J. Biol. Chem., December 17, 2004; 279(51): 53653 - 53664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. C. Orton, J. Ling, A. J. Waskiewicz, J. A. Cooper, W. C. Merrick, N. L. Korneeva, R. E. Rhoads, N. Sonenberg, and J. A. Traugh
Phosphorylation of Mnk1 by Caspase-activated Pak2/{gamma}-PAK Inhibits Phosphorylation and Interaction of eIF4G with Mnk
J. Biol. Chem., September 10, 2004; 279(37): 38649 - 38657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Huang, J. A. Traugh, and J. M. Bishop
Negative Control of the Myc Protein by the Stress-Responsive Kinase Pak2
Mol. Cell. Biol., February 15, 2004; 24(4): 1582 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. S. Miah, K. Sada, P. T. Tuazon, J. Ling, K. Maeno, S. Kyo, X. Qu, Y. Tohyama, J. A. Traugh, and H. Yamamura
Activation of Syk Protein Tyrosine Kinase in Response to Osmotic Stress Requires Interaction with p21-Activated Protein Kinase Pak2/{gamma}-PAK
Mol. Cell. Biol., January 1, 2004; 24(1): 71 - 83.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Gnesutta and A. Minden
Death Receptor-Induced Activation of Initiator Caspase 8 Is Antagonized by Serine/Threonine Kinase PAK4
Mol. Cell. Biol., November 1, 2003; 23(21): 7838 - 7848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wu and Z.-X. Wang
The Mechanism of p21-activated Kinase 2 Autoactivation
J. Biol. Chem., October 24, 2003; 278(43): 41768 - 41778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Jakobi, C. C. McCarthy, M. A. Koeppel, and D. K. Stringer
Caspase-activated PAK-2 Is Regulated by Subcellular Targeting and Proteasomal Degradation
J. Biol. Chem., October 3, 2003; 278(40): 38675 - 38685.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Cotteret, Z. M. Jaffer, A. Beeser, and J. Chernoff
p21-Activated Kinase 5 (Pak5) Localizes to Mitochondria and Inhibits Apoptosis by Phosphorylating BAD
Mol. Cell. Biol., August 15, 2003; 23(16): 5526 - 5539.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. R. Park, A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles
Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages
J. Immunol., June 15, 2003; 170(12): 6209 - 6216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. K. McFawn, L. Shen, S. G. Vincent, A. Mak, J. E. Van Eyk, and J. T. Fisher
Calcium-independent contraction and sensitization of airway smooth muscle by p21-activated protein kinase
Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L863 - L870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Huang, J. Ling, and J. A. Traugh
Localization of p21-activated Protein Kinase gamma -PAK/Pak2 in the Endoplasmic Reticulum Is Required for Induction of Cytostasis
J. Biol. Chem., April 4, 2003; 278(15): 13101 - 13109.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. S. Zatechka Jr, P. F. Kador, S. Garcia-Castineiras, and M. F. Lou
Diabetes Can Alter the Signal Transduction Pathways in the Lens of Rats
Diabetes, April 1, 2003; 52(4): 1014 - 1022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Glantschnig, G. A. Rodan, and A. A. Reszka
Mapping of MST1 Kinase Sites of Phosphorylation. ACTIVATION AND AUTOPHOSPHORYLATION
J. Biol. Chem., November 1, 2002; 277(45): 42987 - 42996.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. R. Lee, S. M. Ramos, A. Ko, D. Masiello, K. D. Swanson, M. L. Lu, and S. P. Balk
AR and ER Interaction with a p21-Activated Kinase (PAK6)
Mol. Endocrinol., January 1, 2002; 16(1): 85 - 99.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Buchwald, E. Hostinova, M. G. Rudolph, A. Kraemer, A. Sickmann, H. E. Meyer, K. Scheffzek, and A. Wittinghofer
Conformational Switch and Role of Phosphorylation in PAK Activation
Mol. Cell. Biol., August 1, 2001; 21(15